What are the primary recommendations for managing symptoms in patients who are dying?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Managing Symptoms in Dying Patients

For patients who are dying, comprehensive symptom management is essential, focusing on pain, dyspnea, and depression as the primary symptoms requiring regular assessment and effective treatment. 1

Key Symptoms to Address

Pain Management

  • Use therapies with proven effectiveness:
    • For cancer patients: NSAIDs, opioids, and bisphosphonates 1
    • For opioid-naive patients: morphine 2.5-10 mg PO every 2 hours as needed or 1-3 mg IV every 2 hours as needed 1
    • For patients already on chronic opioids: consider increasing dose by 25% 1
    • When tapering is necessary, reduce gradually (10-25% of total daily dose) at intervals of 2-4 weeks to avoid withdrawal symptoms 2

Dyspnea Management

  • First-line interventions:
    • Opioids for patients with unrelieved dyspnea 1
    • Oxygen therapy if hypoxic or if subjective relief is reported 1
    • Fans for symptomatic relief 1
    • Benzodiazepines if anxiety is present (lorazepam 0.5-1 mg PO every 4 hours as needed for benzodiazepine-naive patients) 1
  • For excessive secretions:
    • Scopolamine 0.4 mg subcutaneous every 4 hours as needed, or
    • Scopolamine 1.5 mg patches, 1-3 patches every 3 days, or
    • Atropine 1% ophthalmic solution 1-2 drops SL every 4 hours as needed, or
    • Glycopyrrolate 0.2-0.4 mg IV or subcutaneous every 4 hours as needed 1

Depression Management

  • For cancer patients, use:
    • Tricyclic antidepressants
    • Selective serotonin reuptake inhibitors
    • Psychosocial interventions 1
  • Consider mirtazapine 7.5-30 mg at bedtime, which may also help with appetite 1

Anorexia/Cachexia Management

  • Assess meaning of symptoms to patient and family
  • Consider appetite stimulants:
    • Megestrol acetate 400-800 mg/day
    • Olanzapine 5 mg/day
    • Dexamethasone 2-8 mg/day
    • Cannabinoids 1
  • Provide education about natural history of disease, including that absence of hunger and thirst is normal in dying patients 1

Nausea and Vomiting Management

  • Identify and treat underlying causes:
    • Discontinue unnecessary medications
    • Check medication blood levels when appropriate
    • Treat severe constipation if present
    • For gastroparesis: metoclopramide 5-10 mg PO QID before meals and at bedtime
    • For CNS involvement: dexamethasone 4-8 mg BID-TID 1

End-of-Life Care Considerations

When Death is Imminent (Weeks to Days)

  • Intensify palliative interventions
  • Consider palliative sedation for intractable symptoms 1
  • Midazolam is often the first-choice medication for palliative sedation due to its rapid onset and short half-life 1
  • Do not reduce opioid doses solely for decreased blood pressure, respiration rate, or level of consciousness when needed for adequate symptom management 1
  • Discontinue routine monitoring of vital signs; focus only on comfort parameters 1

Family Support

  • Include family in discussions about care plans when possible 1
  • Screen caregivers for practical and emotional needs 1
  • Provide education and emotional support to family members 1
  • Consider respite care for family caregivers to prevent burnout 1

Special Considerations

Nutritional Support

  • Recognize that nutritional support may not be metabolized in advanced cancer
  • Understand that withholding or withdrawing nutrition is ethically permissible and may improve some symptoms
  • Treat dry mouth with local measures (mouth care, small amounts of liquids) 1
  • For patients with diabetes at end of life:
    • Focus on preventing hypoglycemia
    • Consider discontinuing blood glucose monitoring
    • For type 2 diabetes, discontinuation of all medications may be reasonable as the patient approaches death 1

Dignity Preservation

  • Physical symptoms, particularly breathlessness, pain, and fatigue, significantly impact patients' sense of dignity 3, 4
  • Address psychological symptoms which show consistent associations with dignity dimensions 3
  • Equip patients with means for self-care when possible to preserve dignity 4

By systematically addressing these symptoms with proven interventions, healthcare providers can significantly improve quality of life and ensure comfort for patients in their final days.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.